(PMID 11121126)

Heres what you need to know: Target Tissue: Works specifically on adipose tissue without systemic growth hormone effects or muscle tissue impact Mechanism: Activates beta-3 adrenergic receptors on fat cell membranes, triggering intracellular fat-burning cascades Primary Action: Stimulates hormone-sensitive lipase to break down stored triglycerides into free fatty acids for energy utilization Secondary Action: Inhibits lipogenic enzymes that convert excess calories into stored fat Regional Selectivity: Particularly effective on visceral (deep abdominal) and subcutaneous fat deposits with high beta-3 receptor concentration Preservation Effect: Targets fat tissue selectively without promoting muscle protein breakdown or affecting lean tissue Unique Advantage: Does not bind to growth hormone receptors, avoiding effects on IGF-1, glucose metabolism, or insulin sensitivity Research Validation: Clinical trials with 900+ participants confirmed selective fat metabolism effects with excellent safety profile The following guide provides detailed analysis of how AOD-9604 targets fat cells, from receptor binding to metabolic outcomes

It is not meant to replace or substitute medical supervision or regulations but could be considered for the following population: Adults with Stubborn Fat Perfect for individuals who lead a healthy lifestyle and have a difficult time losing localized fat in stubborn areas of their body, such as the waist and thighs
While AOD 9604 is considered to be a GRAS treatment
The peptide can't mobilize fat when insulin is telling your body to store energy
Inhibition of NNMT by 5-Amino-1MQ and Its Effects on Fat Metabolism. Cellular Metabolism , 33(7), 1345-1358